Axsome Therapeutics Correlations
AXSM Stock | USD 127.54 1.13 0.89% |
The current 90-days correlation between Axsome Therapeutics and Incyte is -0.19 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Axsome Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Axsome Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Axsome Therapeutics Correlation With Market
Average diversification
The correlation between Axsome Therapeutics and DJI is 0.18 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Axsome Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Axsome |
Moving together with Axsome Stock
0.65 | VERV | Verve Therapeutics | PairCorr |
0.67 | FENC | Fennec Pharmaceuticals | PairCorr |
0.72 | OPT | Opthea | PairCorr |
0.61 | PHGE | Biomx Inc | PairCorr |
Moving against Axsome Stock
0.86 | ILMN | Illumina Sell-off Trend | PairCorr |
0.75 | NAMSW | NewAmsterdam Pharma Trending | PairCorr |
0.71 | INZY | Inozyme Pharma | PairCorr |
0.67 | EXAS | EXACT Sciences | PairCorr |
0.65 | HLVX | Hillevax | PairCorr |
0.43 | XFOR | X4 Pharmaceuticals | PairCorr |
0.34 | DRMA | Dermata Therapeutics | PairCorr |
0.33 | FATE | Fate Therapeutics | PairCorr |
0.66 | TERN | Terns Pharmaceuticals | PairCorr |
0.66 | CRNX | Crinetics Pharmaceuticals Buyout Trend | PairCorr |
0.66 | CTMX | CytomX Therapeutics | PairCorr |
0.63 | CRBU | Caribou Biosciences | PairCorr |
0.58 | ABOS | Acumen Pharmaceuticals | PairCorr |
0.5 | ADTX | Aditxt Inc | PairCorr |
0.47 | TCRX | Tscan Therapeutics | PairCorr |
0.41 | DAWN | Day One Biopharmaceu | PairCorr |
0.37 | REGN | Regeneron Pharmaceuticals | PairCorr |
0.32 | STRO | Sutro Biopharma | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Axsome Stock performing well and Axsome Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Axsome Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
INCY | 1.40 | 0.08 | 0.04 | 0.28 | 2.22 | 2.65 | 11.46 | |||
IMGN | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
SRPT | 1.75 | (0.01) | 0.00 | (0.04) | 0.00 | 3.58 | 19.63 | |||
ACAD | 2.14 | 0.34 | 0.15 | 0.47 | 2.12 | 5.34 | 15.53 | |||
VKTX | 3.21 | (0.77) | 0.00 | (1.37) | 0.00 | 4.30 | 24.65 | |||
MDGL | 2.73 | 0.13 | 0.04 | 0.15 | 3.54 | 5.53 | 20.65 | |||
MCRB | 3.50 | 0.21 | 0.06 | 0.10 | 3.12 | 8.14 | 28.50 | |||
ICPT | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
TGTX | 2.38 | (0.15) | 0.00 | (0.26) | 0.00 | 5.47 | 14.88 | |||
TERN | 2.99 | (0.56) | 0.00 | (0.52) | 0.00 | 5.17 | 26.61 |
Axsome Therapeutics Corporate Management
Hunter Esq | General Secretary | Profile | |
Amanda PharmD | Senior Development | Profile | |
Lori MBA | Executive Development | Profile | |
Kevin PharmD | Ex Strategy | Profile | |
Mark MA | Chief Officer | Profile |